BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Total operating expenses for the third quarter of 2017 were $5.4 million, compared to $8.0 million for the third quarter of 2016.

  November 13, 2017

   · 

  8 min read
• Drug Development

  80% of Prostate Cancer Patients in OncBioMune Phase I Clinical Trial of ProscaVax Show No Disease Progression at the First Post-Therapy Follow-up

  The latest data updates the progression results at 19 weeks for all 20 patients.

  November 13, 2017

   · 

  2 min read
• ERYTECH to Host Third Quarter 2017 Conference Call and Business Update on November 14, 2017

  ERYTECH announced that it will host a Third Quarter 2017 conference call and webcast on Tuesday, November 14, 2017, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.

  November 13, 2017

   · 

  5 min read
• Drug Development

  ASLAN Pharma Received IND Approval in Singapore to Initiate Phase II Study of ASLAN003 in Acute Myeloid Leukaemia

  The phase II trial is a dose optimisation study, and the primary outcome is to determine the optimum monotherapy dose of ASLAN003 including efficacy evaluated by OCRR.

  November 13, 2017

   · 

  1 min read
• 

  FDA

  Nexstim Gains FDA Clearance to Commercialize Its NBT System to Treat Depression

  The NBT system uses a unique method of TMS known as navigated Transcranial Magnetic Stimulation.

  November 13, 2017

   · 

  2 min read
• Business

  Clementia Reports Third Quarter 2017 Financial Results and Business Highlights

  As of September 30, 2017, Clementia had cash and investments of $152.2 million, which includes the $128.2 million raised in Clementia’s IPO completed in August.

  November 13, 2017

   · 

  10 min read
• Pharm Country

  Philips Showcases Integrated Vascular Solutions at VEITH 2017

  Royal Philips today announced that it will be showcasing its integrated vascular solutions comprising interventional X-ray systems, diagnostic and therapeutic devices, planning and navigation software and services at the 2017 VEITH in New York, New York.

  November 13, 2017

   · 

  4 min read
• Genetown

  MilliporeSigma Introduces Stericup Quick Release System for Improved Cell Culture Filtration

  The Stericup Quick Release system is the next generation of the original Stericup Sterile Vacuum Filtration System, which has been a staple in labs around the world for decades.

  November 13, 2017

   · 

  4 min read
• Biotech Bay

  Science Exchange Scientific Provider Elion Labs presenting New Research at the AAPS Annual Meeting: Breakthrough in Drug Product Particle Analysis Using Machine Learning

  Their AAPS research poster presentation introduces a novel method for drug product analysis, using machine learning and advanced image analysis to improve particle detection, enumeration, and classification.

  November 13, 2017

   · 

  3 min read
• Business

  Intra-Cellular Therapies Expands Its Executive Team with the Appointment of Dr. Andrew Satlin as Executive Vice President and Chief Medical Officer

  Dr. Satlin brings broad experience to the Company with over 20 years of industry experience in all phases of drug development in multiple therapeutic areas.

  November 13, 2017

   · 

  2 min read